Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Software & services

EnWave strikes new licensing and equipment lease agreements with Swiss CBD company

The licenses will allow the Swiss company to process medical-grade hemp for CBD extraction using EnWave’s Radiant Energy Vacuum (REV)

EnWave Corporation (CVE:ENW) (OTCMKTS:NWVCF) is gaining further business traction by striking royalty-bearing licensing and equipment lease agreements with an undisclosed Swiss cannabidiol (CBD) company.

The licenses, which are the Vancouver tech company’s first foray into Europe’s burgeoning hemp market, will allow the Swiss company to process medical-grade hemp for CBD extraction using EnWave’s Radiant Energy Vacuum (REV).

READ: Full interview: EnWave signs evaluation agreement with Mexico-based company for dehydrated fruit snacks

REV is EnWave’s flagship tech created for the dehydration of organic materials. The company has also developed methods for drying and decontaminating cannabis via the use of REV tech, which shorten the period from harvesting to marketing for cannabis products.

Per the terms of the new partnership, the Swiss company will pay EnWave a quarterly royalty based on the number of dried cannabis grams produced in the REV machinery.

Contact Ellen at ellen@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK